Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Skin cells control immune cell placement, helping the skin respond better to challenges.

Hair follicles help skin immune recovery after UVB exposure.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

CD4 T cells can cause alopecia areata by activating CD8 T cells to attack hair follicles.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

CD34-positive cells help repair and form new blood vessels in salivary glands after radiation.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

A specific type of immune cells, called CD301b-expressing macrophages, are crucial for skin repair processes.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Stem cell activity influences autoimmune disease outcomes by affecting immune responses and tissue regeneration.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

People with acne have more CD4+ immune cells in their skin than healthy people.

Scientists found a new type of skin cell that could help with skin repair and these cells work better with a certain protein.

γδTregs can protect hair follicles from alopecia areata and may help regrow hair.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Resident memory T cells and necroptosis may drive fibrosis in eosinophilic fasciitis and morphea.